CDXS sentiment intelligence

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

13 Jul 2026 12:30

Source

Market source

Price to earnings forward of Codexis, Inc. – NASDAQ:CDXS

This article provides the "Price to earnings forward" metric for Codexis, Inc. (NASDAQ:CDXS). It is a brief financial data point for the company, accessible through TradingView. The content primarily focuses on the display of this specific financial metric.

Tone

Neutral 50/100

Event

Earnings

Published

05 Jul 2026 00:41

Source

TradingView

Enterprise value to EBITDA forward of Codexis, Inc. – NASDAQ:CDXS

This article displays the "Enterprise value to EBITDA forward" for Codexis, Inc. (NASDAQ:CDXS) on the TradingView platform. It shows that the market is currently closed with no trades, and provides standard stock market information along with various TradingView features and lega

Tone

Neutral 50/100

Event

Market update

Published

28 Jun 2026 00:09

Source

TradingView

Price to sales forward of Codexis, Inc. – NASDAQ:CDXS

This page displays the forward Price to Sales ratio for Codexis, Inc. (NASDAQ: CDXS). It provides financial data for the company within the Process Industries / Chemicals: Specialty sector, indicating that the market was closed at the time of access with no trades recorded.

Tone

Neutral 50/100

Event

Market update

Published

27 Jun 2026 17:40

Source

TradingView

Codexis (CDXS) shareholders back board nominees, KPMG and pay plan

Codexis, Inc. shareholders voted at the 2026 Annual Meeting to re-elect Stephen G. Dilly, Raymond De Vré, and Rahul Singhvi to the board for three-year terms. They also ratified KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31,

Tone

Neutral 50/100

Event

Market update

Published

22 Jun 2026 10:10

Source

Stock Titan

Form 8K Codexis Inc For: 22 June By Investing.com

This article from Investing.com announces the filing of a Form 8K by Codexis Inc. on June 22. It lists various stock market indices, commodities, and individual stocks with their current prices and daily changes. The article also highlights popular news related to tech companies

Tone

Neutral 50/100

Event

Market update

Published

22 Jun 2026 10:10

Source

Investing.com Canada

Codexis (CDXS) director receives option grant for 66,350 shares

Codexis (CDXS) director Esther Martinborough received a stock option grant for 66,350 shares at an exercise price of $2.48 per share. These options vest upon the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent on her continued

Tone

Neutral 50/100

Event

Market update

Published

19 Jun 2026 17:10

Source

Stock Titan

Codexis (NASDAQ: CDXS) director receives 66,350 options vesting in one year

Codexis (NASDAQ: CDXS) director Rahul Singhvi was granted 66,350 stock options with an exercise price of $2.48 per share, expiring on June 17, 2036. The options vest fully on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, conditiona

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 21:09

Source

Stock Titan

Codexis (CDXS) director David V. Smith granted 66,350 stock options at $2.48

Codexis (CDXS) director David V. Smith was granted 66,350 stock options with an exercise price of $2.48 per share, expiring on June 17, 2036. This grant serves as equity compensation and is not an open-market trade. The options will vest on the earlier of the first anniversary of

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 20:47

Source

Stock Titan

Director at Codexis (CDXS) receives 66,350 stock options grant

Codexis (CDXS) director Cynthia Collins was granted 66,350 stock options with an exercise price of $2.48 per share. These options vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting and expire in 2036. This transaction is a form o

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 20:47

Source

Stock Titan

CODEXIS (CDXS) director receives 66,350 stock options at $2.48 strike price

CODEXIS director Christos Richards was granted 66,350 stock options with an exercise price of $2.48 per share. These options, awarded at no cost, will vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, provided Richards

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 20:47

Source

Stock Titan

Codexis (CDXS) director Parker H. Stewart receives 66,350 stock options

Codexis (CDXS) director Parker H. Stewart has been granted 66,350 stock options with an exercise price of $2.48 per share, expiring on June 17, 2036. The options will vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 20:47

Source

Stock Titan

Codexis (CDXS) director Raymond De Vre awarded 66,350 stock options at $2.48

Codexis (CDXS) director Raymond De Vre was granted 66,350 stock options with an exercise price of $2.48 per share, expiring on June 17, 2036. The options will vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 20:09

Source

Stock Titan

Codexis (CDXS) grants director 66,350 stock options at $2.48

Codexis (CDXS) director Stephen George Dilly was granted 66,350 stock options at an exercise price of $2.48 per share, as part of his compensation package. These options will vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, pr

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 20:09

Source

Stock Titan

Codexis Inc (CDXS) Shareholder Structure: Major Shareholders & Institutional Holdings

The article details the shareholder structure of Codexis Inc (CDXS), listing its major shareholders and their proportions, including abrdn Inc., Opaleye Management Inc., and BlackRock Institutional Trust Company, N.A. It also categorize shareholders by type, such as investment ad

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 09:47

Source

TradingKey

Codexis Inc (CDXS) Institutional Confidence

Codexis Inc (CDXS) has an institutional shareholding score of 7.00, placing it 81st out of 388 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 73.00%, a 13.55% decrease quarter-over-quarter. Bill Nygren, holding 332.07K shares, is th

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 06:39

Source

TradingKey

Codexis Inc (CDXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Codexis Inc (CDXS), detailing its financial performance by region. As of April 6, the company's total revenue was $70.49 million, with America contributing the largest share at 61.85%. Data for business segments and profit contributio

Tone

Neutral 50/100

Event

Earnings

Published

18 Jun 2026 01:10

Source

TradingKey

CDXS: All proposals, including director elections and auditor ratification, were approved without contest

During the Codexis, Inc. (CDXS) 2026 AGM, all proposals, including director elections and auditor ratification, were approved without contest. A quorum was confirmed, and no stockholder questions were raised. The voting results for these approved proposals will be officially repo

Tone

Neutral 50/100

Event

Earnings

Published

17 Jun 2026 17:10

Source

TradingView

Codexis director Raymond de Vre sells $6,173 in shares

Codexis director Raymond De Vre sold 2,605 shares of the company's common stock for $6,173 to cover tax liabilities from Restricted Stock Units. Following the sale, Mr. De Vre directly holds 84,811 shares. This transaction occurs after Codexis shares surged 44% in six months and

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 02:09

Source

Investing.com

Codexis (CDXS) director De Vre sells 2,605 shares to cover RSU tax liability

Codexis director Raymond De Vre sold 2,605 shares of common stock for $2.37 per share on June 11, 2026. This sale was primarily to cover tax liabilities associated with vested Restricted Stock Units (RSUs) and is considered a mechanical transaction rather than a discretionary inv

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 00:40

Source

Stock Titan

Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA

Codexis highlighted new advancements in RNA therapeutic manufacturing at TIDES USA 2026, focusing on its ECO Synthesis Manufacturing Platform. The company demonstrated full-length siRNA synthesis with precise stereochemical control and introduced the ability to initiate enzymatic

Tone

Neutral 50/100

Event

Market update

Published

21 May 2026 04:40

Source

Yahoo! Finance Canada

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Tone

Neutral 50/100

Event

Earnings

Published

14 May 2026 07:00

Source

Market source